These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 24004348

  • 1. Fibrinogen and FXIII dose response effects on albumin-induced coagulopathy.
    Hanna J, Winstedt D, Schött U.
    Scand J Clin Lab Invest; 2013 Oct; 73(7):553-62. PubMed ID: 24004348
    [Abstract] [Full Text] [Related]

  • 2. Albumin-induced coagulopathy is less severe and more effectively reversed with fibrinogen concentrate than is synthetic colloid-induced coagulopathy.
    Winstedt D, Hanna J, Schött U.
    Scand J Clin Lab Invest; 2013 Mar; 73(2):161-9. PubMed ID: 23368782
    [Abstract] [Full Text] [Related]

  • 3. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution.
    Haas T, Fries D, Velik-Salchner C, Reif C, Klingler A, Innerhofer P.
    Anesth Analg; 2008 May; 106(5):1360-5, table of contents. PubMed ID: 18420845
    [Abstract] [Full Text] [Related]

  • 4. The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model.
    Shenkman B, Livnat T, Lubetsky A, Tamarin I, Budnik I, Einav Y, Martinowitz U.
    Blood Coagul Fibrinolysis; 2012 Jul; 23(5):370-8. PubMed ID: 22498982
    [Abstract] [Full Text] [Related]

  • 5. The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro.
    Schlimp CJ, Cadamuro J, Solomon C, Redl H, Schöchl H.
    Blood Transfus; 2013 Oct; 11(4):510-7. PubMed ID: 23245725
    [Abstract] [Full Text] [Related]

  • 6. Role of fibrinogen-, factor VIII- and XIII-mediated clot propagation in gelatin haemodilution.
    Schramko AA, Kuitunen AH, Suojaranta-Ylinen RT, Niemi TT.
    Acta Anaesthesiol Scand; 2009 Jul; 53(6):731-5. PubMed ID: 19239406
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Correction of hypothermic and dilutional coagulopathy with concentrates of fibrinogen and factor XIII: an in vitro study with ROTEM.
    Winstedt D, Thomas OD, Nilsson F, Olanders K, Schött U.
    Scand J Trauma Resusc Emerg Med; 2014 Dec 16; 22():73. PubMed ID: 25510409
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High-dose fibrinogen versus a clinically recommended dose of fresh frozen plasma for reversal of dilutional coagulopathy in an in vitro model of severe hemodilution.
    Rosenthal C, Rau J, Volk T, Sander M, Ziemer S, Von Heymann C.
    Minerva Anestesiol; 2014 Aug 16; 80(8):894-903. PubMed ID: 24398441
    [Abstract] [Full Text] [Related]

  • 12. Is dilutional coagulopathy induced by different colloids reversible by replacement of fibrinogen and factor XIII concentrates?
    Kind SL, Spahn-Nett GH, Emmert MY, Eismon J, Seifert B, Spahn DR, Theusinger OM.
    Anesth Analg; 2013 Nov 16; 117(5):1063-71. PubMed ID: 24029856
    [Abstract] [Full Text] [Related]

  • 13. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%.
    De Lorenzo C, Calatzis A, Welsch U, Heindl B.
    Anesth Analg; 2006 Apr 16; 102(4):1194-200. PubMed ID: 16551923
    [Abstract] [Full Text] [Related]

  • 14. The effects of haemodilution with albumin on coagulation in vitro as assessed by rotational thromboelastometry.
    Pathirana S, Wong G, Williams P, Yang K, Kershaw G, Dunkley S, Kam PC.
    Anaesth Intensive Care; 2015 Mar 16; 43(2):187-92. PubMed ID: 25735683
    [Abstract] [Full Text] [Related]

  • 15. In vitro effects of different sources of fibrinogen supplementation on clot initiation and stability in a model of dilutional coagulopathy.
    Schäfer N, Driessen A, Bauerfeind U, Fröhlich M, Ofir J, Stürmer EK, Maegele M.
    Transfus Med; 2016 Oct 16; 26(5):373-380. PubMed ID: 27506588
    [Abstract] [Full Text] [Related]

  • 16. Thromboelastographic evaluation of coagulative profiles in pig-to-monkey kidney xenotransplantation.
    Spiezia L, Boldrin M, Radu C, Bulato C, Bertini D, Bon M, Campello E, Vadori M, Galli C, Gavasso S, Nottle MB, Cowan PJ, Cozzi E, Simioni P.
    Xenotransplantation; 2013 Oct 16; 20(2):89-99. PubMed ID: 23406330
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates.
    He S, Johnsson H, Zabczyk M, Hultenby K, Wallén H, Blombäck M.
    Thromb Haemost; 2014 Mar 03; 111(3):417-28. PubMed ID: 24196490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.